![David W. Ghesquiere](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David W. Ghesquiere
Corporate Officer/Principal bei
OMEROS CORPORATION
Profil
David W.
Ghesquiere is the founder of Adrenaline Venture & Advisory LLC, founded in 2012, where the title held was Managing Director from 2012 to 2013.
The current job is Chief Business Development Officer & VP at Omeros Corp.
starting in 2024.
Former jobs include Director-Global Business Development at Aventis Pharmaceuticals, Inc. from 2000 to 2005; Senior VP-Corporate & Business Development, MD at OSI Pharmaceuticals, Inc. from 2005 to 2010; Secretary, Director & Managing Director at OSI Investment Management GmbH from 2009 to 2010; Secretary, Director & Managing Director at Osi Investment Holdings GmbH from 2009 to 2010; Senior VP-Corporate & Business Development at Dendreon Corp.
from 2011 to 2012; and Senior VP-Corporate & Business Development at NS Wind Down Co., Inc. from 2013 to 2023.
Education includes undergraduate studies at the University of Western Ontario and an MBA from Richard Ivey School of Business.
Aktive Positionen von David W. Ghesquiere
| Unternehmen | Position | Beginn |
|---|---|---|
| OMEROS CORPORATION | Corporate Officer/Principal | 01.08.2024 |
Ehemalige bekannte Positionen von David W. Ghesquiere
| Unternehmen | Position | Ende |
|---|---|---|
| NS WIND DOWN CO., INC. | Corporate Officer/Principal | 01.12.2023 |
Adrenaline Venture & Advisory LLC
 Adrenaline Venture & Advisory LLC Investment ManagersFinance Provides investment advisory services | Vorstandsvorsitzender | 01.11.2013 |
| DENDREON CORPORATION | Corporate Officer/Principal | 01.01.2012 |
Osi Investment Holdings GmbH | Direktor/Vorstandsmitglied | 01.12.2010 |
OSI Investment Management GmbH | Direktor/Vorstandsmitglied | 01.12.2010 |
Ausbildung von David W. Ghesquiere
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
80
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Omeros Corp.
 Omeros Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small-molecule & protein therapeutics | Health Technology |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NS Wind Down Co., Inc.
 NS Wind Down Co., Inc. Medical SpecialtiesHealth Technology Develops and manufactures life science tools for translational research and molecular diagnostic products | Health Technology |
OSI Investment Management GmbH | |
Richard Ivey School of Business
 Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Osi Investment Holdings GmbH | |
Adrenaline Venture & Advisory LLC
Adrenaline Venture & Advisory LLC Investment ManagersFinance Provides investment advisory services | Finance |
